Emily Hill
Board Member
Ptc Therapeutics, Inc. (PTCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Current
-
Start not stated–2023-08-20
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Replimune Group, Inc. (REPL) | Chief Financial Officer | $516,500 | $1,594,953 |
| 2024 | Replimune Group, Inc. (REPL) | Chief Financial Officer | $266,538 | $3,383,157 |
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Financial Officer | $367,530 | $2,336,648 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.